BiotechTube

60 mg ulixacaltamide + Placebo

Phase 3Recruiting
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Essential Tremor

Conditions

Essential Tremor

Trial Timeline

Nov 2, 2023 → Dec 1, 2026

NCT ID
NCT06087276

About 60 mg ulixacaltamide + Placebo

60 mg ulixacaltamide + Placebo is a phase 3 stage product being developed by Praxis Precision Medicines for Essential Tremor. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06087276. Target conditions include Essential Tremor.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT06087276Phase 3Recruiting

Competing Products

20 competing products in Essential Tremor

See all competitors
ProductCompanyStageHype Score
L04RD1 + L04TD3CelltrionPhase 1
33
Azilsartan MedoxomilCelltrionPre-clinical
23
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mgCelltrionPhase 3
77
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
85
Anagre Cap.YuhanApproved
85
Telmisartan/Amlodipine/Chlorthalidone(Truset)YuhanPre-clinical
23
olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo + olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil/hydrochlorothiazide tablets + olmesartan medoxomil/hydrochlorothiazide tabletsDaiichi SankyoPhase 3
77
olmesartan medoxomil + hydrochlorothiazide, if necessary + losartan + hydrochlorothiazide, if necessaryDaiichi SankyoPhase 3
77
CS8635 20/5/12.5mg and placebo + Olmetec® Plus 20/12.5mg and placeboDaiichi SankyoPhase 3
77
CS-3150 + olmesartan medoxomilDaiichi SankyoPre-clinical
23
olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo + Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipineDaiichi SankyoPhase 3
77
Olmesartan medoxomil + Atenolol + Hydrochlorothiazide + olmesartan medoxomil + atenololDaiichi SankyoPhase 3
77
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
85
CS-3150 + EplerenoneDaiichi SankyoPhase 3
77
olmesartan medoxomil + losartan potassiumDaiichi SankyoPhase 3
77
Olmesartan medoxomil 40 mg - Amlodipine 10 mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 25mgDaiichi SankyoPhase 3
77
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
85
Olmesartan medoxomil + Losartan + Furosemide oral tabletsDaiichi SankyoPhase 3
77
olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mgDaiichi SankyoPhase 3
77
olmesartan medoxomil + amlodipineDaiichi SankyoPhase 3
77

Other Products from Praxis Precision Medicines

vormatroginePhase 3
74
1.0mg/kg/day PRAX-562 + 1.5mg/kg/day PRAX-562 + PlaceboPhase 3
74
1mg elsunersen + 0.5mg elsunersenPhase 3
74
20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks + PlaceboPhase 2/3
62
PRAX-562Phase 2/3
62